MFG
BLTE

Merit Financial Group’s Belite Bio BLTE Stock Holding History

Merit Financial Group’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,415
Closed -$226K – 2373
2026
Q1 		$226K Buy
+1,415
New +$238K ﹤0.01% 1848

Other funds holding BLTE

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Merit Financial Group's BLTE Position: Q2 2026 in Review

Merit Financial Group sold out of Belite Bio (BLTE) in Q2 2026, closing a stake of 1,415 shares — an estimated $226K sold.

Merit Financial Group first reported a position in BLTE in Q1 2026 and held it in 1 quarter. The position peaked at $226K in Q1 2026. 3 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Merit Financial Group reported no remaining Belite Bio position as of Q2 2026 after selling out during the quarter.
  • Merit Financial Group sold 1,415 Belite Bio shares in Q2 2026, an estimated $226K.
  • Merit Financial Group first reported a position in Belite Bio in Q1 2026 and held it in 1 quarter.
  • Merit Financial Group's Belite Bio position peaked at $226K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.